Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quest Pharmatech Inc V.QPT

Alternate Symbol(s):  QPTFF

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. It also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.


TSXV:QPT - Post by User

Post by PosNeg1on Mar 10, 2022 7:13pm
188 Views
Post# 34504931

Hmm

HmmTechnology for you. Make the New Industry Dool Mulsan Co., Ltd., which puts its heart into technology , consideration, and automobile technology for a safe and convenient life, pursues constant innovation and is doing its best to become a leader in the automobile parts industry . Dool Mulsan Co., Ltd. 4th floor, 445 Teheran-ro, Gangnam-gu, Seoul TEL 02.6925.2177 Copyright DUAL CORPORATION. All rights reserved. Dear Shareholders of Doool Mulsan and Dool Mulsan Holdings Dear shareholders of Doool Mulsan and Dool Mulsan Holdings, how are you? This is Dool Mulsan CEO Na Han-ik and Dool Mulsan Holdings CEO Lee Chang-hyeon. The securities declaration (merger) submitted to the Financial Supervisory Service came into effect on February 10, 2022. The current merger date is scheduled for February 18, 2022, and we will proceed with the merger process as scheduled and complete it without any setbacks. Thank you to the shareholders who have been waiting for this. 2022. 02. 10 Dool Trading CEO Na Han-ik Chang-hyeon Lee, CEO of Doool Mulsan Holdings
<< Previous
Bullboard Posts
Next >>